Bone gamma-carboxyglutamic acid-containing protein and Matrix Gla protein (BGLAP and MGP)

Osteocalcin (BGLAP) and Matrix Gla Protein (MGP) are critical vitamin K-dependent proteins (VKDPs) that regulate mineralization in the skeletal and vascular systems, respectively (Source: UniProt P02818, P08490). Osteocalcin, synthesized by osteoblasts, is essential for bone matrix organization and also functions as an endocrine hormone that modulates glucose metabolism and energy expenditure (Source: PubMed PMID: 30503116). Matrix Gla Protein is primarily produced by vascular smooth muscle cells and acts as a powerful local inhibitor of arterial calcification, preventing the deposition of calcium phosphate in the vessel walls (Source: PubMed PMID: 26003332). Both proteins require post-translational gamma-carboxylation of specific glutamate residues to achieve their functional calcium-binding state, a process dependent on vitamin K as a cofactor (Source: StatPearls, Vitamin K). In clinical practice, the under-carboxylated forms of these proteins (ucOC and ucMGP) serve as significant biomarkers for vitamin K status and are associated with increased risks of osteoporosis and cardiovascular disease (Source: PubMed PMID: 29149820). Therapeutic strategies targeting these proteins include vitamin K supplementation to enhance their protective functions and the careful management of vitamin K antagonists like warfarin, which can paradoxically promote vascular stiffness by inhibiting MGP activation (Source: PubMed PMID: 31683753).

Other names

OsteocalcinBGLAPBone Gla proteinMGPMatrix Gla proteinBone gamma-carboxyglutamic acid-containing protein

Vitamin K-dependent gamma-carboxylation of glutamate residues by gamma-glutamyl carboxylase (GGCX) activates these proteins, enabling them to bind calcium ions and hydroxyapatite (Source: PubMed PMID: 26003332).